the aid library

LIST OPTIONS

Filter

10164

Download (398)

View PDF (654)

Indonesia: Pharmaceuticals in Health Care Delivery - Mission Report 10 - 23 July 2011

K. A. Holloway, World Health Organization (WHO) (2011) C_WHO

Download (253)

View PDF (209)

Panorama of Diabetes in the Americas by Pan American Health Organization

Pan American Health Organization PAHO (2022) C_WHO

The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The... more

Download (956)

View PDF (1159)

WHO Tanzania Country Cooperation Strategy 2022-27

World Health Organization; Regional Office for Africa (2022) C_WHO

The Country Cooperation Strategy (CCS) is a document to guide WHO’s work in countries. CCS is a medium-term vision for WHO’s technical cooperation with a given Member State, and supports the country's national health policy, strategy or plan. The CCS time frame is flexible to align with national... more

Download (370)

View PDF (559)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (256)

View PDF (390)

An investment case for new tuberculosis vaccines

World Health Organisation (WHO) (2022) C_WHO

This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in... more

Download (341)

View PDF (328)

Antibacterial agents in preclinical development: an open access database

World Health Organization WHO (2019) C_WHO

The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens. However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for... more

External Link

Antimicrobial Stewardship from Principles to Practice

British Society for antimicrobial chemotherapy BSAC (2018) C2

Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ... more

Download (198)

View PDF (171)

Impact of community-led and community-based HIV service delivery beyond HIV: case studies from eastern and southern Africa

UNAIDS (2025) C1

The objectives of the research presented in this report were to identify case studies of community-led HIV-related health and social inclusion service delivery organizations in eastern and southern Africa; describe the typologies of the services provided; and identify evidence of their service deliv... more

External Link

Non communicable diseases kit 2016 (NCDK)

WHO Regional Office for the Eastern Mediterranean (2017) C_WHO

WHO has developed a new health kit to support treatment for chronic disease patients in emergency settings. The prevalence of NCDs is increasing worldwide, including in emergency/crisis-prone areas. Yet current humanitarian response has not accounted for this emerging burden. The NCD kit attends to ... more

Download (262)

View PDF (504)

Update of recommendations on first- and second-line antiretroviral regimens - Policy Brief

World Health Organization (2019) C_WHO

HIV Treatment

Download (279)

View PDF (289)

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 5

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO

Module 5 Monitoring and Evaluation October 2018 Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona... more

Download (383)

View PDF (293)

Human T-lymphotropic virus type 1: technical report

World Health Organization WHO (2021) C_WHO

Download (311)

View PDF (445)

Draft Department of basic educational policy on HIV, STIs and TB

Department of Basic Education; Department of Basic Education: Republic of South Africa (2015) C2

STAATSKOERANT, 5 MEI 2015 No. 38763 No. 38763 GOVERNMENT GAZETTE, 5 MAY 2015 General Notice Notice 295 of 2015 Department of basic education National education policy act, 1996 (Act No 27 of 1996) Call for written submissions from stakeholder bodies and members of the public on Departmen... more

Download (382)

View PDF (562)

Public–private mix for TB prevention and care: a roadmap

World Health Organization WHO (2018) C_WHO

In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i... more

Download (286)

View PDF (348)

Media Brief on Prevention of Mother-to-Child Transmission for Zambian Journalists

Panos Institute Southern Africa (2012) C1

Download (372)

View PDF (532)

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO

Download (808)

View PDF (733)

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more

Download (917)

View PDF (2061)

The Economic Impact of the 2014 Ebola Epidemic

The World Bank (2014)

Download (209)

View PDF (227)

The WHO AWaRe (Access, Watch, Reserve) antibiotic book - Infographics

World Health Organisation (WHO) (2022) C_WHO

Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug... more

Download (397)

View PDF (378)

Persons with Disabilities: Status in the Philippines

Edgardo F. Garcia, MPA (2014) C1